Summary.-The long-term effects of Adriamycin (ADR), daunomycin (DMN) and cis-dichlorodiammine platinum (II) (DDP) on the ability of murine renal tubular epithelium and erythropoiesis to respond to an acute proliferative stress was investigated. Folic acid (FA) and acute anaemia induced by bleeding were used as acute proliferative stimuli for renal-tubule epithelium and erythropoiesis respectively. The ability of these normal cell-renewal systems to mount a regenerative proliferative response was evaluated by radioisotopic, morphological and gravimetric techniques 4 months after drug treatment. The results indicate that pretreatment with these agents produce a long-lasting reduction in the ability of these cell-renewal systems to mount regenerative proliferation. In the kidney, the ability to respond to FA was most severely compromised by ADR and DDP, whereas in the erythropoietic system all 3 agents induced a long-lasting proliferative defect.
THE DEVELOPMENT of new therapeutic drugs, new techniques and machines in radiotherapy, and new conceptual approaches to sequential and combinedmodality therapy has led to significant improvements in cancer treatment. These advances, however, have not been made without attendant toxicity to critical normal tissues. Acute toxicity from chemotherapeutic drugs can be clinically documented with relative ease, but delayed toxicity or the potential for late adverse interactions with radiation are difficult to predict, and often difficult to manage (Tefft et al., 1976; Random et al., 1979) . Pulmonary fibrosis after bleomycin (Nygaard et al., 1978) , gastrointestinal complications after Adriamycin (ADR) and radiation (Mayer et al., 1976; Phillips & Fu, 1976 , Ransom et al., 1979 and long-lasting renal injury after cis-dichlorodiammine platinum (II) (DDP) (Ansair et al., 1980; Bruno et al., 1980; Bobrow, 1972; Dentino et al., 1978; Freeman et al., 1979 ) have been documented. These and other delayed toxicities are most likely manifestations of a reduced ability to mount a regenerative response to a cytotoxic insult in normal cell-renewal systems.
In experimental animal models, longlasting proliferative defects induced by chemotherapeutic drugs and radiation have been studied in haemopoietic (Gong et al., 1969; Botnick et al., 1978) , lymphopoietic (Botnick et al., 1978) and intestinal (Schenken et al., 1979) cell-renewal systems. We have now extended our studies on delayed proliferative defects in the kidney after DDP (Braunschweiger et al., 1980b) to include the delayed effects of ADR and daunomycin (DMN) in both the renal-tubule epithelium and haemopoietic cell-renewal systems.
METHODS AND MATERIALS
Mice and drug treatments-.Male BDF1 mice (Jax) used throughout these studies were housed, 6-8/cage, in animal quarters The proliferative response to anaemic stress was evaluated as previously described (Braunschweiger et al., 1980b) . At 120 days after drug treatment, pretreated and untreated controls were bled 1/3 of their calculated blood volume from the postorbital venous plexus at each of 2 sessions 24 h apart. Before each bleeding, mice were injected i.p.
with a volume of warm 0.9% NaCl equal to the predetermined blood volume to be removed. Before killing, 48 h after induction of anaemia, haematocrit determinations were made on bled and non-bled groups. The bleeding procedure routinely halved the haematocrit. The mice were killed by cervical dislocation and the spleens and femurs removed. The spleens were weighed and minced in bovine serum (GIBCO, Grand Island, NY, U.S.A.). The suspension was filtered through nylon gauze, and aliquots were then applied to microscope slides with a cytocentrifuge (Cytospin, Shandon Elliott, Sewickley, PA, U.S.A.). Femoral marrow cytocentrifuge preparations were similarly prepared (Braunschweiger et al., 1980b) . The fraction of nucleated erythroid precursors were determined by counting at least 500 cells in Wright-Giemsa-stained spleen and marrow preparations.
In both the kidney and the erythropoietic system, proliferative-response deficits were assessed by comparing proliferative parameters in stressed and non-stressed pretreated mice to those in age-matched controls. In kidney studies, integrated cell production during the course of the FA response was estimated by determining the area under the post-stress time-course curves. The relative cell production in drug-pretreated mice was expressed as a percentage of control. The t test was used when appropriate to assess significant differences. P < 0 05 was taken as rejecting the null hypothesis.
RESULTS

Renal tubule regeneration
By 24 h after FA, the kidneys were pale yellow with focal haemorrhages.
Histologically, the tubular epithelium was swollen, with cytoplasmic vacuolation as well as nuclear fragmentation. Brightly staining eosinophilic material and sloughed cells were seen in the lumen of the tubules. The glomeruli appeared to be unaffected. The tubular lesions are probably a manifestation of local changes in electrolyte balance induced by the precipitation of FA at neutral or acid pH (Threlfall et al., 1966; Byrnes et al., 1972b) . The findings are not inconsistent with nephrotoxic acute renal failure and tubular necrosis (Baserga et al., 1968; Byrne et al., 1972a, b No mortality was seen in the other treated groups. Fig. 3 shows the changes in the LI of cortical tubular epithelium after FA (125 mg/kg in saline). LIs were significantly increased 12 h after FA in control kidneys. Maximal LI, noted 36 h after treatment, was increased about 140-fold. In mice pretreated with DDP or ADR, the response was delayed and subnormal for 72 h. The response in DMN-treated mice closely paralleled that in the controls.
If all tubular epithelial cells that take up [3H]dT subsequently divide, the area under the d/min/kidney and LI timecourse curves would be proportional to the total cell production during the experiment. The relative proliferative responses of the renal epithelium in drug-pretreated mice are shown in Table I . Although the magnitude of the LI response was greater than that for d/min/kidney, the relative integral deficits in cell production for these two response parameters were similar. Whilst 1-3 mg/kg DMN produced only a 25% deficient response at 120 days, the deficits in ADR-(70.4%) and DDP (54.3%) -treated mice were more severe.
The deficiency in response could also be estimated from the ratio of the LI response in pretreated mice at 36 h to that in controls. These data indicate that, although DMN induced only a modest long-term renal injury, ADR and DDP caused significant long-term reduction in the renal proliferative reserve.
Erythropoiesis
Anaemic stress induced by bleeding was used to evaluate the ability of the spleen and femoral marrow to mount a regenerative response to an acute proliferative demand 120 days after drug treatment. Table II shows spleen weights and erythrocyte-precursor fractions in femoral marrows and spleen before and 48 h after bleeding. Control spleen weights increased -5000 after bleeding, whereas, spleen weights in pretreated mice increased only by 20%. The nucleated erythrocyteprecursor fractions in spleens and femoral marrows from control mice increased by 500%o and 100% respectively. In pretreated mice, although significant erythroid responses were noted in the spleen (DMN) and femoral marrows (DDP, ADR), all responses were significantly subnormal.
DISCUSSION
Clinically observed delayed toxicities appear to be a consequence of drug-or radiation-induced reductions in the ability of the cell renewal system to provide differentiated cells. This could be a result of reduced stem-cell numbers (multiplicity), subnormal stem-cell proliferation (proliferative reserve) or both. Although acute toxicities are the major clinical concern in the design of therapeutic strategies, delayed proliferation defects resulting from aggressive treatments could increase the acute toxicities after subsequent treatments. A better understanding of the limitations and sensitivities of normal cell-renewal systems may provide some insight into ways in which persistent long-term injury can be minimized.
In experimental animal models we and others have used acute anaemia induced by bleeding as an erythropoietic stress (Braunschweiger et al., 1980a, b; Gong et al., 1969) , acute abdominal radiation as an acute GI stress (Schenken et al., 1979) , serial marrow transplantation as a specific proliferative stress for the CFUs (Botnick et al., 1978) , and unilateral nephrectomy (Donaldson et al., 1978 and unpublished; Moskowitz et al., 1980; Resnick et al., 1972) as a specific proliferative stimuli to detect and quantitate long-lasting proliferative defects before they become manifest as life-threatening toxicities. In the kidney, high-dose FA has been used to study the morphological (Byrne et al., 1972b) and biochemical (Baserga et al., 1968; Byrnes et al., 1972a; Taylor et al., 1966; Threlfall et al., 1966 Threlfall et al., , 1967 events leading to initiation of DNA synthesis after acute renal failure. In the present studies, the time course and magnitude of th9 proliferative response to FA-induced tubular necrosis in the controls was similar to that observed by Baserga et al. (1968) .
un comparison with the respective control values, both d/min/kidney and LI endpoints gave similar estimates of the response deficits in DDP-and ADRpretreated mice. In rats, Taylor et al. (1976) observed subnormal FA responses up to 10 days after 4 mg/kg DDP. The response at longer intervals was not, however studied. More recently Kovacs et al. (1981) showed that proliferative homoeostasis in mouse kidney is not re-established until about 45 days after 8 mg/kg DDP. The proliferative response to FA at this time was also subnormal. In these studies the response deficit was about 75% at 45 days. In the present study the response deficit was about 55% 120 days after DDP, suggesting that the proliferative defect repaired slowly, with a recovery half-time of at least 120 days.
Clinically DDP has been clearly shown to induce long-lasting renal injury (Ansair et al., 1980; Bruno et al., 1980; Dentino et al., 1978; Freeman et al., 1979) which may in part be due to the rather slow clearance (Handelsman et al., 1974; Litterst et al., 1979) . Although renal toxicity from ADR has not been identified as a significant clinical problem in adults, children treated for Wilms' tumour demonstrated subnormal compensatory renal growth after chemotherapy or radiationchemotherapy combinations (Arneil et al., 1974) . In animal models, anthracycline drugs have been shown to be nephrotoxic (Moskowitz et al., 1980; Sternberg, 1970) . In young mice, ADR treatment after unilateral nephrectomy induced a longlasting delay in compensatory renal regrowth which was most probably related to a delay in unilateral-nephrectomyinduced mitosis. A similar effect has been found in compensating kidneys after mithramycin (Resnick et al., 1972) , radiation (Donaldson et al., 1978) and combined-modality therapy (Donaldson et al., unpublished) . Although renal-function tests were not done in the present studies, drug-induced inhibition of compensatory renal regrowth after nephrectomy has been shown to be associated with late morphological and functional abnormalities (Donaldson et al., unpublished) .
In marrows and spleens 1-3 mg/kg DMN produced a similar level of erythropoietic injury to 10 mg/kg ADR, even though DMN produced little long-lasting renal injury. Previous studies have indicated that both agents are rapidly cleared from the plasma, highly concentrated in the kidney, and slowly cleared and excreted in the urine (Schwartz & Grindey, 1979; Siemann & Sutherland, 1979; Yesair et al., 1972) . DMN is, however, concentrated more in the haemopoietic tissues than is ADR (Schwartz & Grindey, 1979) . Further, DMN has been shown to be 2-3 times more toxic than ADR for haemopoietic stem cells (Razek et al., 1972) .
From the standpoint of renal injury, DMN is more rapidly metabolized than ADR, and the initial renal clearance may also be more rapid. Thus, concentration time for DMN in kidney could be substantially less than for ADR (Yesair, etal., 1972) .
We have previously shown that both ADR (Braunschweiger et al., 1980b) and DDP (Braunschweiger et al., 1980a) can induce long-lasting dose-dependent proliferative defects in the haemopoietic system of Ha/ICR mice. The results in the present studies, using BDF1 mice, are not inconsistent with our previous findings. Furthermore, Lohrmann et al. (1978) demonstrated a long-lasting residual haemopoietic defect in patients receiving adjuvant chemotherapy with cyclophosphamide and ADR. In these studies sub-normal circulating CFU-C levels were found up to 3 years after treatment.
The underlying mechanism of the druginduced reduction in proliferative reserve is unclear. This defect might be a manifestation of improperly repaired molecular injury, persistent intracellular drug retention, or perhaps irreparable injury to stroma or other tissues performing support functions during induced proliferation. Studies addressed to these and other questions regarding time-dose modifications of these proliferative defects are continuing.
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